For many years, Hyperbaric has provided laboratories with a trusted quality control for verifying blood gas analyzer performance at extremely high pO₂ values. We are excited to announce the next evolution of this trusted product.

Today, Hyperbaric CSR is available alongside the current ampoule version.

Hyperbaric CSR combines the proven Hyperbaric formulation with our innovative CueSee® Ringe sampling technology, making testing easier, safer and more convenient while maintaining the performance laboratories rely on, learn more:

Why Hyperbaric CSR?

• More cost-efficient and convenient with 15-minute open-vial stability to test multiple analyzers

• Safer sample handling with reduced risk of handling errors

• Same trusted Hyperbaric performance

Transition Timeline

From January 1, 2027

The traditional ampoule version will be discontinued and Hyperbaric CSR will become the standard product available worldwide.

We encourage laboratories to begin evaluating Hyperbaric CSR and transition at a time that best fits their validation and inventory planning.

If you have any questions about the transition or would like assistance implementing Hyperbaric CSR, our team will be happy to help.